India has moved from tech follower to global leader in science and innovation: Jitendra Singh
The minister credited this shift to a 'supportive political dispensation' after 2014 that allowed scientists the freedom to experiment even when success wasn't guaranteed.
Speaking at a press conference following detailed presentations by four major science departments, Singh said, 'The last 11 years turned technology into the engine of India's growth story. More importantly, we are no longer a technology follower but a technology leader.' India is now setting global best practices in science and innovation rather than waiting to adopt them from abroad, he added.
New Delhi, Jun 23 (PTI) Minister of State for Science and Technology Jitendra Singh on Monday said India has transformed into a global leader in science and technology over the past decade driven by a political climate that enabled scientific risk-taking and innovation.
'What a scientist needs most is the liberty to try and that space was given to us by the hon'ble prime minister,' he said, pointing to reforms like opening up space and nuclear sectors to private participation and encouraging global collaborations.
Emphasising that India never lacked talent but previously lacked policy support, Singh said the country had moved away from working in silos and was now witnessing convergence between public and private sectors.
'In other countries, there is no hard demarcation between public and private in scientific work. We have started moving in that direction,' he noted.
Ajay Sood, Principal Scientific Adviser (PSA) to the Government of India, echoed the minister's remarks and praised the transformative shift in India's science and technology landscape.
'You would have all noticed that in the last 11 years, science and technology has moved from the sidelines to the centre stage of national development,' said Sood, adding that four science departments had clearly demonstrated this journey through their presentations.
He explained that the office of the PSA plays a key role in providing evidence-based and ministry-agnostic scientific advice to the prime minister and the Cabinet, identifying gaps and recommending national missions.
'We are not tied to any one ministry. Our focus is on mapping the entire scientific landscape and ensuring cross-sectoral coordination,' Sood said.
He noted that under the Prime Minister's Science, Technology and Innovation Advisory Council (PM-STIAC), 11 targeted national missions, including the National Quantum Mission, National One Health Mission, Deep Ocean Mission, and the Green Hydrogen Mission, have been initiated. These were based on identified priority areas and implemented by the concerned departments for coordinated national impact.
Sood also highlighted the significance of the Anusandhan National Research Foundation (ANRF), calling it 'a very, very important initiative' that had its genesis in early discussions within the PSA office before its formal rollout last year. PTI UZM AS AS
This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Print
an hour ago
- The Print
Favipiravir drug shows promise against Chandipura virus in preclinical studies by NIV
Studies on mice have shown that Favipiravir can reduce viral load and improve survival rates in infected animals, Dr Naveen Kumar, Director of NIV, which is under the Indian Council of Medical Research (ICMR), told PTI. The Chandipura virus (CHPV) is endemic in central India and symptoms include high fever and seizures. The infection also induces encephalitis. New Delhi, Jun 24 (PTI) Anti-viral drug Favipiravir has been found to have the potential to provide substantial protection against the Chandipura virus in the preclinical studies conducted by the Pune-based National Institute of Virology(NIV). The virus was identified during 1965 in Maharashtra from clinical samples of febrile cases. The first significant outbreak was recorded in 2003 in Telangana, which was then part of Andhra Pradesh. It infected over 300 children with more than 50 per cent fatality. Cases were also reported from Vidarbha region of Maharashtra, Telangana and Gujarat between 2003 and 2007. Even 2007 onwards sporadic cases from endemic regions were reported. In 2024, a major outbreak was reported from Gujarat and adjoining areas of Maharashtra which the WHO described as the largest outbreak in the past 20 years. It emerged to be a major threat for the paediatric population with 64 laboratory confirmed cases of the infection reported from Gujarat (61 cases) and adjoining areas, Dr Vijay Bondre, senior scientist at NIV, said. The outbreak was investigated by the National Joint Outbreak Response Team, Dr Bondre said. 'The NIV has been working toward identifying potential anti-virals against CHPV. In the search after testing multiple anti-virals, Favipiravir has been identified to give substantial protection against the Chandipura virus infection which has also been established in the preclinical trials in the laboratory,' explained Dr Kumar. So far the findings suggest that Favipiravir could be a potential therapeutic option for these infections, he said. 'Clinical trials on humans are yet to be carried out to confirm its efficacy and safety in humans,' Dr Kumar stated. Dr Bondre said before proceeding to testing on human, the efficacy of the drug against CHPV on animals will be re-established at another organisation – ICMR-National Animal Research Facility for Biological research. This will take another seven to eight months. Currently, the infection is managed through symptomatic treatment and there is no particular drug which is used for its treatment. In addition to it, the NIV has initiated research to develop a vaccine candidate against CHPV. The research will be of great help to the nation to minimise the high fatality due this infection among children, Dr Kumar said. The CHPV is a member of Rhabdoviridae family and is transmitted by arthropod vectors, most probably sand flies. Vector control, hygiene and awareness are the only measures available against the disease. The disease affects mostly children under 15 years of age and can present with a febrile illness that may progress to convulsions, coma and in some cases may result in death, Dr Bondre said. PTI PLB DV DV This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Time of India
3 hours ago
- Time of India
India has moved from tech follower to global leader in science & innovation: Jitendra Singh
New Delhi: Minister of State for Science and Technology Jitendra Singh on Monday said India has transformed into a global leader in science and technology over the past decade driven by a political climate that enabled scientific risk-taking and innovation. Speaking at a press conference following detailed presentations by four major science departments, Singh said, "The last 11 years turned technology into the engine of India's growth story. More importantly, we are no longer a technology follower but a technology leader." India is now setting global best practices in science and innovation rather than waiting to adopt them from abroad, he added. The minister credited this shift to a "supportive political dispensation" after 2014 that allowed scientists the freedom to experiment even when success wasn't guaranteed. "What a scientist needs most is the liberty to try and that space was given to us by the hon'ble prime minister," he said, pointing to reforms like opening up space and nuclear sectors to private participation and encouraging global collaborations. Emphasising that India never lacked talent but previously lacked policy support, Singh said the country had moved away from working in silos and was now witnessing convergence between public and private sectors. "In other countries, there is no hard demarcation between public and private in scientific work. We have started moving in that direction," he noted. Ajay Sood , Principal Scientific Adviser (PSA) to the Government of India, echoed the minister's remarks and praised the transformative shift in India's science and technology landscape. "You would have all noticed that in the last 11 years, science and technology has moved from the sidelines to the centre stage of national development," said Sood, adding that four science departments had clearly demonstrated this journey through their presentations. He explained that the office of the PSA plays a key role in providing evidence-based and ministry-agnostic scientific advice to the prime minister and the Cabinet, identifying gaps and recommending national missions. "We are not tied to any one ministry. Our focus is on mapping the entire scientific landscape and ensuring cross-sectoral coordination," Sood said. He noted that under the Prime Minister's Science, Technology and Innovation Advisory Council (PM-STIAC), 11 targeted national missions, including the National Quantum Mission , National One Health Mission, Deep Ocean Mission, and the Green Hydrogen Mission, have been initiated. These were based on identified priority areas and implemented by the concerned departments for coordinated national impact. Sood also highlighted the significance of the Anusandhan National Research Foundation (ANRF), calling it "a very, very important initiative" that had its genesis in early discussions within the PSA office before its formal rollout last year.
The Print
6 hours ago
- The Print
India's Shubhanshu Shukla's Axiom-4 mission now targeting June 25 launch
'NASA, Axiom Space, and SpaceX are targeting 2:31 a.m. EDT (12:01 IST), Wednesday, June 25, for launch of the fourth private astronaut mission to the International Space Station, Axiom Mission 4,' a NASA statement said. The Axiom-4 mission, which marks the return to space for India, Hungary, and Poland, was earlier scheduled for lift-off from NASA's Kennedy Space Centre in Florida on June 25 onboard SpaceX's Falcon 9 rocket at 12:01 pm IST on Wednesday. New Delhi, Jun 24 (PTI) Indian astronaut Shubhanshu Shukla's Axiom-4 mission to the International Space Station is now eyeing a launch on June 25, NASA announced on Tuesday. The Axiom-4 commercial mission is led by Commander Peggy Whitson, with Shukla as mission pilot and Hungarian astronaut Tibor Kapu and Poland's Slawosz Uznanski-Wisniewski as mission specialists. The mission was originally scheduled for lift-off on May 29 but was then put off to June 8, then June 10 and June 11, when engineers detected a liquid oxygen leak in the boosters of the Falcon-9 rocket and NASA also detected leaks in the ageing Russian module of the International Space Station. The launch was then planned for June 19 and then on June 22 which was put off to allow NASA evaluate operations of the ISS after repairs in the Russian module. The mission will lift off from Launch Complex 39A at NASA's Kennedy Space Centre in Florida. The crew will travel to the orbiting laboratory on a new SpaceX Dragon spacecraft after launching on the company's Falcon 9 rocket. The targeted docking time is approximately 7 am (4:30 pm IST) Thursday, June 26, NASA said. PTI SKU SCY This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
